News Biofrontera Deutsche Boerse AG

Equities

B8F

DE0006046113

Delayed Deutsche Boerse AG Other stock markets 02:18:04 2024-05-13 am EDT			5-day change	1st Jan Change
0.298 ^EUR	-12.87%		-.--%	-.--%

May. 31	Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 15	Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 31	CI
Biofrontera : Quarterly Report 1st Quarter Q1/2024	May. 31	PU
Biofrontera : RULES OF PROCEDURE of the Supervisory Board	May. 26	PU
Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M	May. 15	MT
Biofrontera : Subscription offer (CONVENIENCE TRANSLATION)	May. 14	PU
Reverse Split: 1 of 21; Rights Issue: 1 new share @ 1.1 EUR of 1 existing share	May. 13	FA
Rights Issue: 1 new share @ 1.1 EUR for 1 existing share	May. 13	FA
Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30	CI
Biofrontera Files Prospectus for Potential Secondary Stock Offerings	Mar. 11	MT
Medicus Pharma Names COO	Mar. 05	MT
BIOFRONTERA AG ANNOUNCES REVISED STRATEGY	Feb. 21	AQ
BIOFRONTERA AG, BIOFRONTERA TRANSFERS CLINICAL RESEARCH TO THE U.S.	Feb. 21	AQ
Biofrontera AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Earnings Flash (BFRI) BIOFRONTERA Reports Q3 Revenue $8.9M, vs. Street Est of $8.4M	Nov. 09	MT
Biofrontera Licensor Gets FDA Approval for New Formulation of Ameluz to Treat Actinic Keratosis	23-10-10	MT
Biofrontera Says Sun Pharmaceutical Alleging Breach of Contract In Lawsuit	23-10-03	DJ
Biofrontera AG Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Biofrontera Says Skin Disease Therapy Was Well-Tolerated in Phase 1 Safety Trial	23-08-28	MT
Earnings Flash (BFRI) BIOFRONTERA Reports Q2 Revenue $5.8M	23-08-11	MT
Biofrontera Completes Patient Enrollment in Skin Cancer Treatment Study	23-08-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Biofrontera Deutsche Boerse AG

Equities

B8F

DE0006046113

Summary

Filters